Lyell Immunopharma Inc 2024年度报告
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aL:LL>LLF>GMH?MA>>??><MBO>G>LLH?BMLBGM>KG:E<HGMKHEHO>K?BG:G<B:EK>IHKMBG@NG=>K/><MBHG;H?MA>/:K;:G>L +QE>R <M1 / ;;RMA>K>@BLM>K>=IN;EB<:<<HNGMBG@?BKFMA:MIK>I:K>=HKBLLN>=BML:N=BMK>IHKM %?L><NKBMB>L:K>K>@BLM>K>=INKLN:GMMH/><MBHG;H?MA> <M BG=B<:M>;R<A><DF:KDPA>MA>KMA>?BG:G<B:ELM:M>F>GMLH?MA>K>@BLMK:GMBG<EN=>=BGMA>?BEBG@K>?E><MMA><HKK><MBHGH?:G>KKHKMHIK>OBHNLERBLLN>=?BG:G<B:ELM:M>F>GML %G=B<:M>;R<A><DF:KDPA>MA>K:GRH?MAHL>>KKHK<HKK><MBHGL:K>K>LM:M>F>GMLMA:MK>JNBK>=:K><HO>KR:G:ERLBLH?BG<>GMBO> ;:L>=<HFI>GL:MBHGK><>BO>=;R:GRH?MA>K>@BLMK:GMaL>Q><NMBO>H??B<>KL=NKBG@MA>K>E>O:GMK><HO>KRI>KBH=INKLN:GMMHV ; %G=B<:M>;R<A><DF:KDPA>MA>KMA>K>@BLMK:GMBL:LA>EE<HFI:GR:L=>?BG>=BG.NE>; H?MA> <M 5>L*H 0A>:@@K>@:M>F:KD>MO:EN>H?MA><HFFHGLMH<DA>E=;RGHG :??BEB:M>LH?MA>K>@BLMK:GMHG&NG> MA>E:LM;NLBG>LL=:RH?MA>K>@BLMK:GMaLFHLMK><>GMER<HFIE>M>=L><HG=?BL<:EJN:KM>K P:L:IIKHQBF:M>ERFBEEBHG;:L>=HGMA><EHLBG@IKB<>K>IHKM>=?HKLN<A=:M>HG0A>*:L=:J#EH;:E/>E><M):KD>M 0A>K>@BLMK:GMA:= LA:K>LH?<HFFHGLMH<DHNMLM:G=BG@:LH?):K<A !' &%!$"!$&+$$ ,HKMBHGLH?MA>K>@BLMK:GMaL,KHQR/M:M>F>GM?HKMA> GGN:E)>>MBG@H?/MH<DAHE=>KL:K>BG<HKIHK:M>=A>K>BG;RK>?>K>G<>BG,:KM%%%H?MABL GGN:E.>IHKMHG"HKF 'MHMA>>QM>GMLM:M>=A>K>BG /N<AIKHQRLM:M>F>GMPBEE;>?BE>=PBMAMA>/><NKBMB>L:G=!Q<A:G@> HFFBLLBHGPBMABG=:RLH?MA>K>@BLMK:GMaL?BL<:ER>:K>G=>=><>F;>K E28899A:;<5.>9.:0::A.8$2<;>@;:;>9 &./82;3;:@2:@? ".42/I><B:E*HM>.>@:K=BG@"HKP:K= (HHDBG@/M:M>F>GML/NFF:KRH?.BLD":<MHKL"$&%M>F NLBG>LL%M>F .BLD":<MHKL%M>F 1GK>LHEO>=/M:?? HFF>GML%M>F R;>KL><NKBMR%M>F,KHI>KMB>L%M>F(>@:E,KH<>>=BG@L%M>F)BG>/:?>MRBL<EHLNK>L"$&%M>F):KD>M?HK.>@BLMK:GMaL HFFHG!JNBMR .>E:M>=/MH<DAHE=>K):MM>KL:G=%LLN>K,NK<A:L>LH?!JNBMR/><NKBMB>L%M>F7.>L>KO>=8%M>F):G:@>F>GMa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
